scholarly journals Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504)

BMC Cancer ◽  
2012 ◽  
Vol 12 (1) ◽  
Author(s):  
Chouaid Christos ◽  
◽  
Le Caer Hervé ◽  
Locher Chrystelle ◽  
Dujon Cecile ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell ◽  
Line Treatment ◽  
Phase 2 ◽  
Small Cell Lung ◽  
First Line ◽  
Phase 2 Study ◽  
Prospective Phase ◽  
First Line Treatment

scholarly journals A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

2013 ◽  
Vol 8 (3) ◽  
pp. 329-337 ◽  
Author(s):  
Luis Paz-Ares ◽  
Beatrix Bálint ◽  
Richard H. de Boer ◽  
Jan P. van Meerbeeck ◽  
Rafal Wierzbicki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Small Cell ◽  
Line Treatment ◽  
Phase 2 ◽  
Small Cell Lung ◽  
First Line ◽  
Phase 2 Study ◽  
Randomized Phase 2 ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document